Abstract
The pathogenesis of bipolar disorder (BPD) is unknown. Using human-induced pluripotent stem cells (hiPSCs) to unravel pathological mechanisms in polygenic diseases is challenging, with few successful studies to date. However, hiPSCs from BPD patients responsive to lithium have offered unique opportunities to discern lithium’s mechanism of action and hence gain insight into BPD pathology. By profiling the proteomics of BPD–hiPSC-derived neurons, we found that lithium alters the phosphorylation state of collapsin response mediator protein-2 (CRMP2). The “set point” for the ratio of pCRMP2:CRMP2 is elevated uniquely in hiPSC-derived neurons from lithium responsive (Li-R) BPD patients, but not other psychiatric and neurological disorders. Utilizing neurons differentiated from human patient stem cells as an in vitro platform, we were able to elucidate the mechanism driving the pathogenesis and pathophysiology of lithium-responsive BPD, heretofore unknown. Importantly, the findings in culture were validated in human postmortem material as well as in animal models of BPD behavior. These data suggest that the “lithium response pathway” in BPD governs CRMP2’s phosphorylation, which regulates cytoskeletal organization, particularly in dendritic spines, leading to modulated neural networks that may underlie Li-R BPD pathogenesis. This chapter reviews the methodology of leveraging a functional agent, lithium, to identify unknown pathophysiological pathways with hiPSCs and how to translate this disease modeling approach to other neurological disorders.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Althoff RR, Faraone SV, Rettew DC, Morley CP, Hudziak JJ (2005) Family, twin, adoption, and molecular genetic studies of juvenile bipolar disorder. Bipolar Disord 7(6):598–609. https://doi.org/10.1111/j.1399-5618.2005.00268.x
American Psychiatric Association (2013) Bipolar and related disorders. In: Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC
Bennett JP Jr, O’Brien LC, Brohawn DG (2016) Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosis. Biochem Pharmacol 117:68–77. https://doi.org/10.1016/j.bcp.2016.08.001
Brittain JM, Piekarz AD, Wang Y, Kondo T, Cummins TR, Khanna R (2009) An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J Biol Chem 284(45):31375–31390. https://doi.org/10.1074/jbc.M109.009951
Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL et al (2011) Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca(2)(+) channel complex. Nat Med 17(7):822–829. https://doi.org/10.1038/nm.2345
Brittain JM, Wang Y, Eruvwetere O, Khanna R (2012) Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2. FEBS Lett 586(21):3813–3818. https://doi.org/10.1016/j.febslet.2012.09.022
Brown KM, Tracy DK (2013) Lithium: the pharmacodynamic actions of the amazing ion. Ther Adv Psychopharmacol 3(3):163–176. https://doi.org/10.1177/2045125312471963
Byers B, Cord B, Nguyen HN, Schule B, Fenno L, Lee PC et al (2011) SNCA triplication Parkinson’s patient’s iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS One 6(11):e26159. https://doi.org/10.1371/journal.pone.0026159
Cao L, McDonnell A, Nitzsche A, Alexandrou A, Saintot PP, Loucif AJ et al (2016) Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia. Sci Transl Med 8(335):335ra356. https://doi.org/10.1126/scitranslmed.aad7653
Chin EW, Marcy G, Yoon SI, Ma D, Rosales FJ, Augustine GJ, Goh EL (2016) Choline ameliorates disease phenotypes in human iPSC models of rett syndrome. Neuromol Med 18(3):364–377. https://doi.org/10.1007/s12017-016-8421-y
Chung SY, Kishinevsky S, Mazzulli JR, Graziotto J, Mrejeru A, Mosharov EV et al (2016) Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and alpha-synuclein accumulation. Stem Cell Rep 7(4):664–677. https://doi.org/10.1016/j.stemcr.2016.08.012
Codazzi F, Hu A, Rai M, Salerno Scarzella F, Mangiameli E, Pelizzoni I et al (2016) Friedreich ataxia induced pluripotent stem cell-derived neurons show a cellular phenotype that is corrected by a benzamide HDAC inhibitor. Hum Mol Genet 25(22):4847–4855. https://doi.org/10.1093/hmg/ddw308
Cole AR, Causeret F, Yadirgi G, Hastie CJ, McLauchlan H, McManus EJ et al (2006) Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo. J Biol Chem 281(24):16591–16598. https://doi.org/10.1074/jbc.M513344200
Desbordes SC, Studer L (2013) Adapting human pluripotent stem cells to high-throughput and high-content screening. Nat Protoc 8(1):111–130. https://doi.org/10.1038/nprot.2012.139
Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T et al (2012) Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med 4(145):145ra104. https://doi.org/10.1126/scitranslmed.3004052
Gershon S, Chengappa KN, Malhi GS (2009) Lithium specificity in bipolar illness: a classic agent for the classic disorder. Bipolar Disord 11(Suppl 2):34–44. https://doi.org/10.1111/j.1399-5618.2009.00709.x
Goshima Y (1997) Regulation of growth cone motility by the repulsive factor collapsin/semaphorin: a role of collapsin response mediator protein (CRMP). Seikagaku 69(12):1389–1392 http://www.ncbi.nlm.nih.gov/pubmed/9483985
Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM (1995) Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376(6540):509–514. https://doi.org/10.1038/376509a0
Hofman MA (1985) Size and shape of the cerebral cortex in mammals. I. The cortical surface. Brain Behav Evol 27(1):28–40 http://www.ncbi.nlm.nih.gov/pubmed/3836731
Hofman MA (1988) Size and shape of the cerebral cortex in mammals. II. The cortical volume. Brain Behav Evol 32(1):17–26 http://www.ncbi.nlm.nih.gov/pubmed/3056571
Kaufmann M, Schuffenhauer A, Fruh I, Klein J, Thiemeyer A, Rigo P et al (2015) High-throughput screening using iPSC-derived neuronal progenitors to identify compounds counteracting epigenetic gene silencing in fragile X syndrome. J Biomol Screen 20(9):1101–1111. https://doi.org/10.1177/1087057115588287
Khanna R, Wilson SM, Brittain JM, Weimer J, Sultana R, Butterfield A, Hensley K (2012) Opening Pandora’s jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders. Future Neurol 7(6):749–771. https://doi.org/10.2217/FNL.12.68
Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93(16):8455–8459. http://www.ncbi.nlm.nih.gov/pubmed/8710892, http://www.pnas.org/content/93/16/8455.full.pdf
Konopaske GT, Lange N, Coyle JT, Benes FM (2014) Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiat 71(12):1323–1331. https://doi.org/10.1001/jamapsychiatry.2014.1582
Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, Nakashima K, Gage FH (2010) L1 retrotransposition in neurons is modulated by MeCP2. Nature 468(7322):443–446. https://doi.org/10.1038/nature09544
Nakamura H, Yamashita N, Kimura A, Kimura Y, Hirano H, Makihara H et al (2016) Comprehensive behavioral study and proteomic analyses of CRMP2-deficient mice. Genes Cells 21(10):1059–1079. https://doi.org/10.1111/gtc.12403
Ramón y Cajal S (1995) Histology of the nervous system of man and vertebrates. Oxford University Press, New York
Rochefort NL, Konnerth A (2012) Dendritic spines: from structure to in vivo function. EMBO Rep 13(8):699–708. https://doi.org/10.1038/embor.2012.102
Smoller JW, Finn CT (2003) Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 123C(1):48–58. https://doi.org/10.1002/ajmg.c.20013
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872. https://doi.org/10.1016/j.cell.2007.11.019
Tobe BTD, Crain AM, Winquist AM, Calabrese B, Makihara H, Zhao WN et al (2017) Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis. Proc Natl Acad Sci USA 114(22):E4462–E4471. https://doi.org/10.1073/pnas.1700111114
Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, Yamashita N et al (2005) Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer’s disease. Genes Cells 10(2):165–179. https://doi.org/10.1111/j.1365-2443.2005.00827.x
WHO (1995) The World Health Report 1995—bridging the gaps. World Health Forum 16(4):377–385 http://www.ncbi.nlm.nih.gov/pubmed/8534341
Wilson SM, Brittain JM, Piekarz AD, Ballard CJ, Ripsch MS, Cummins TR et al (2011) Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex. Channels (Austin) 5(5):449–456. https://doi.org/10.4161/chan.5.5.17363
Wilson SM, Xiong W, Wang Y, Ping X, Head JD, Brittain JM et al (2012) Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization. Neuroscience 210:451–466. https://doi.org/10.1016/j.neuroscience.2012.02.038
Yahata N, Asai M, Kitaoka S, Takahashi K, Asaka I, Hioki H et al (2011) Anti-Abeta drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer’s disease. PLoS One 6(9):e25788. https://doi.org/10.1371/journal.pone.0025788
Yamashita N, Ohshima T, Nakamura F, Kolattukudy P, Honnorat J, Mikoshiba K, Goshima Y (2012) Phosphorylation of CRMP2 (collapsin response mediator protein 2) is involved in proper dendritic field organization. J Neurosci 32(4):1360–1365. https://doi.org/10.1523/JNEUROSCI.5563-11.2012
Zheng Y, Sethi R, Mangala L, Taylor C, Goldsmith J, Wang M et al (2018) Tuning microtuble dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation. Nat Commun 9(1):476. https://doi.org/10.1038/s41467-017-02811-7
Zhu LQ, Zheng HY, Peng CX, Liu D, Li HL, Wang Q, Wang JZ (2010) Protein phosphatase 2A facilitates axonogenesis by dephosphorylating CRMP2. J Neurosci 30(10):3839–3848. https://doi.org/10.1523/JNEUROSCI.5174-09.2010
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Pernia, C.D. et al. (2018). Modeling Complex Neurological Diseases with Stem Cells: A Study of Bipolar Disorder. In: Buzanska, L. (eds) Human Neural Stem Cells. Results and Problems in Cell Differentiation, vol 66. Springer, Cham. https://doi.org/10.1007/978-3-319-93485-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-93485-3_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-93484-6
Online ISBN: 978-3-319-93485-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)